Operating Lease, Liability in USD of Evelo Biosciences, Inc. from Q1 2020 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Evelo Biosciences, Inc. quarterly Operating Lease, Liability history and change rate from Q1 2020 to Q3 2023.
Evelo Biosciences, Inc. Operating Lease, Liability for the quarter ending 30 Sep 2023 was $0.000, a 100% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Evelo Biosciences, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$0	-$8.11M	-100%	30 Sep 2023	10-Q	09 Nov 2023
Q2 2023	$6.57M	-$2.11M	-24.3%	30 Jun 2023	10-Q	14 Aug 2023
Q1 2023	$6.92M	-$2.29M	-24.8%	31 Mar 2023	10-Q	15 May 2023
Q4 2022	$7.52M	-$2.21M	-22.7%	31 Dec 2022	10-Q	09 Nov 2023
Q3 2022	$8.11M	-$2.14M	-20.9%	30 Sep 2022	10-Q	14 Nov 2022
Q2 2022	$8.67M	-$2.07M	-19.2%	30 Jun 2022	10-Q	11 Aug 2022
Q1 2022	$9.21M	-$2M	-17.8%	31 Mar 2022	10-Q	12 May 2022
Q4 2021	$9.74M	-$1.93M	-16.5%	31 Dec 2021	10-K	16 Mar 2023
Q3 2021	$10.2M	-$1.86M	-15.4%	30 Sep 2021	10-Q/A	29 Oct 2021
Q2 2021	$10.7M	-$2.03M	-15.9%	30 Jun 2021	10-Q	29 Jul 2021
Q1 2021	$11.2M	-$2.05M	-15.5%	31 Mar 2021	10-Q	29 Apr 2021
Q4 2020	$11.7M			31 Dec 2020	10-K	09 Mar 2021
Q3 2020	$12.1M			30 Sep 2020	10-Q	30 Oct 2020
Q2 2020	$12.8M			30 Jun 2020	10-Q	31 Jul 2020
Q1 2020	$13.3M			31 Mar 2020	10-Q	11 May 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.